Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription 15.04.2024 2 Acta Neuropathol 1 Am J Alzheimers Dis Other Demen 1 Am J Geriatr Psychiatry 1 BMC Neurol 4 Brain 4 Brain Res 2 Dement Geriatr Cogn Disord 2 Exp Gerontol 13 J Alzheimers Dis 1 J Neurochem 3 Neurobiol Aging 1 Neurobiol Dis 1 Neurol Clin Pract 1 Neurology 1 Neuropsychology 1 Neuroreport 1 Neurosci Lett 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. THAL DR, Gawor K, Moonen S
   Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis.
   Acta Neuropathol. 2024;147:69.
   PubMed         Abstract available
   
   
2. BHATTARAI P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, et al
   Rare genetic variation in fibronectin 1 (FN1) protects against APOEepsilon4 in Alzheimer's disease.
   Acta Neuropathol. 2024;147:70.
   PubMed         Abstract available
   
   

   
   Am J Alzheimers Dis Other Demen

3. CHIANG YK, Lin YS, Chen CY, Lirng JF, et al
   Different Splice Isoforms of Peripheral Triggering Receptor Expressed on Myeloid Cells 2 mRNA Expressions are Associated With Cognitive Decline in Mild Dementia Due to Alzheimer's Disease and Reflect Central Neuroinflammation.
   Am J Alzheimers Dis Other Demen. 2024;39:15333175241243183.
   PubMed         Abstract available
   
   

   
   Am J Geriatr Psychiatry

4. JANG S, Chen J
   National Estimates of Incremental Work Absenteeism Costs Associated With Adult Children of Parents With Alzheimer's Disease and Related Dementias.
   Am J Geriatr Psychiatry. 2024 Mar 28:S1064-7481(24)00294.
   PubMed         Abstract available
   
   

   
   BMC Neurol

5. LANE RM, Darreh-Shori T, Junge C, Li D, et al
   Onset of Alzheimer disease in apolipoprotein varepsilon4 carriers is earlier in butyrylcholinesterase K variant carriers.
   BMC Neurol. 2024;24:116.
   PubMed         Abstract available
   
   

   
   Brain

6. 
   Correction to: Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia.
   Brain. 2024 Apr 10:awae103. doi: 10.1093.
   PubMed        
   
   
7. WANG YT, Therriault J, Servaes S, Tissot C, et al
   Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
   Brain. 2024;147:1497-1510.
   PubMed         Abstract available
   
   
8. TANAKA H, Martinez-Valbuena I, Forrest SL, Couto B, et al
   Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
   Brain. 2024;147:1399-1411.
   PubMed         Abstract available
   
   
9. CORRIVEAU-LECAVALIER N, Barnard LR, Botha H, Graff-Radford J, et al
   Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases.
   Brain. 2024;147:1483-1496.
   PubMed         Abstract available
   
   

   
   Brain Res

10. HE R, Al-Tamimi J, Sanchez-Benavides G, Montana-Valverde G, et al
    Atypical cortical hierarchy in Abeta-positive older adults and its reflection in spontaneous speech.
    Brain Res. 2024;1830:148806.
    PubMed         Abstract available
    
    
11. PEI MQ, Xu LM, Yang YS, Chen WC, et al
    Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders.
    Brain Res. 2024;1830:148821.
    PubMed         Abstract available
    
    
12. REZAUL ISLAM M, Akash S, Murshedul Islam M, Sarkar N, et al
    Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights.
    Brain Res. 2024 Apr 4:148886. doi: 10.1016/j.brainres.2024.148886.
    PubMed         Abstract available
    
    
13. YANG Y, Jia X, Yang X, Wang J, et al
    Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
    Brain Res. 2024;1835:148920.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

14. NAKAGAWA K, Kanai S, Kitakaze S, Okamura H, et al
    Discriminant accuracy of standing balance tests for level of gait dependency in hospitalized patients with Alzheimer's disease.
    Dement Geriatr Cogn Disord. 2024 Apr 10. doi: 10.1159/000538541.
    PubMed         Abstract available
    
    
15. PELEGRINI LNC, da Silva VA, Grigoli MM, Vatanabe IP, et al
    Plasma ADAM10 Levels and their Association with Alzheimer's Disease Diagnosis in Older Adults with Fewer Years of Formal Education.
    Dement Geriatr Cogn Disord. 2024 Apr 6. doi: 10.1159/000538630.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

16. SHAO Z, Lu Y, Xing A, He X, et al
    Effect of outer membrane vesicles of Lactobacillus pentosus on Tau phosphorylation and CDK5-Calpain pathway in mice.
    Exp Gerontol. 2024;189:112400.
    PubMed         Abstract available
    
    
17. DOU J, Zhang X, Hu C, Gao Y, et al
    QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE.
    Exp Gerontol. 2024 Apr 8:112422. doi: 10.1016/j.exger.2024.112422.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

18. HAN SL, Ou YN, Han BL, Guo HH, et al
    Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline.
    J Alzheimers Dis. 2024;98:1133-1143.
    PubMed         Abstract available
    
    
19. SACHDEVA P, Narayanan KB, Sinha JK, Gupta S, et al
    Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 6. doi: 10.3233/JAD-231181.
    PubMed         Abstract available
    
    
20. COGUT V, McNeely TL, Bussian TJ, Graves SI, et al
    Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
    J Alzheimers Dis. 2024;98:925-940.
    PubMed         Abstract available
    
    
21. TSENG WI, Hsu YC, Huang LK, Hong CT, et al
    Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:1095-1106.
    PubMed         Abstract available
    
    
22. MARTINEZ-DUBARBIE F, Lopez-Garcia S, Lage C, Di Molfetta G, et al
    Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
    J Alzheimers Dis. 2024;98:1029-1042.
    PubMed         Abstract available
    
    
23. O'SHEA DM, Camacho S, Ezzeddine R, Besser L, et al
    The Mediating Role of Cortical Atrophy on the Relationship between the Resilience Index and Cognitive Function: Findings from the Healthy Brain Initiative.
    J Alzheimers Dis. 2024;98:1017-1027.
    PubMed         Abstract available
    
    
24. PODGER L, Stewart WF, Serrano D, Lipton RB, et al
    Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.
    J Alzheimers Dis. 2024;98:1079-1094.
    PubMed         Abstract available
    
    
25. CEYZERIAT K, Jaques E, Gloria Y, Badina A, et al
    Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.
    J Alzheimers Dis. 2024;98:1001-1016.
    PubMed         Abstract available
    
    
26. PAPADIMITRIOU A, Dawson AZ, Thorgerson A, Bhandari S, et al
    Understanding the Relationship Between Wealth and Cognitive Function by Race/Ethnicity Among Older United States Adults with Diabetes.
    J Alzheimers Dis. 2024;98:1145-1155.
    PubMed         Abstract available
    
    
27. BECKERS E, Riphagen JM, Van Egroo M, Bennett DA, et al
    Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231328.
    PubMed         Abstract available
    
    
28. BINI J
    The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231463.
    PubMed         Abstract available
    
    
29. SANCHEZ-SOBLECHERO A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al
    Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?
    J Alzheimers Dis. 2024;98:957-967.
    PubMed         Abstract available
    
    
30. BERGAMINO M, Keeling E, McElvogue M, Schaefer SY, et al
    White Matter Microstructure Analysis in Subjective Memory Complaints and Cognitive Impairment: Insights from Diffusion Kurtosis Imaging and Free-Water DTI.
    J Alzheimers Dis. 2024;98:863-884.
    PubMed         Abstract available
    
    

    
    J Neurochem

31. 
    The following article for this Special Issue was previously published and can be found in its respective issue online: "Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4".
    J Neurochem. 2024;168:e2.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

32. INAGAKI R, Yamakuni T, Saito T, Saido TC, et al
    Preventive effect of propolis on cognitive decline in Alzheimer's disease model mice.
    Neurobiol Aging. 2024;139:20-29.
    PubMed         Abstract available
    
    
33. ROYSE SK, Snitz BE, Hill AV, Reese AC, et al
    Apolipoprotein E and Alzheimer's disease pathology in African American older adults.
    Neurobiol Aging. 2024;139:11-19.
    PubMed         Abstract available
    
    
34. BRANSBY L, Yassi N, Rosenich E, Buckley R, et al
    Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults.
    Neurobiol Aging. 2024;138:63-71.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

35. XIE B, Yang S, Hao Y, Sun Y, et al
    Impaired olfactory identification in dementia-free individuals is associated with the functional abnormality of the precuneus.
    Neurobiol Dis. 2024;194:106483.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

36. GRILL JD, Raman R, Ernstrom K, Wang S, et al
    Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial.
    Neurol Clin Pract. 2024;14:e200265.
    PubMed         Abstract available
    
    

    
    Neurology

37. DITTRICH A, Westman E, Shams S, Skillback T, et al
    Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study.
    Neurology. 2024;102:e209402.
    PubMed         Abstract available
    
    

    
    Neuropsychology

38. MCKAY NS, Millar PR, Nicosia J, Aschenbrenner AJ, et al
    Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research.
    Neuropsychology. 2024 Apr 11. doi: 10.1037/neu0000949.
    PubMed         Abstract available
    
    

    
    Neuroreport

39. KRESS GT, Popa ES, Merrill DA, Bramen JE, et al
    The impact of physical exercise on hippocampal atrophy in mild cognitive impairment and Alzheimer's disease: a meta-analysis.
    Neuroreport. 2024 Apr 12. doi: 10.1097/WNR.0000000000002037.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

40. ZHANG Y, Wu F
    Diagnostic value and cognitive regulatory roles of long non-coding RNA UCA1 in Alzheimer's disease.
    Neurosci Lett. 2024 Apr 5:137765. doi: 10.1016/j.neulet.2024.137765.
    PubMed         Abstract available
    
    

    
    Neuroscience

41. DENG J, Liu B, Tao Q, Luo Y, et al
    The co-oligomers of Abeta42 and human islet amyloid polypeptide exacerbate neurotoxicity and Alzheimer-like pathology at cellular level.
    Neuroscience. 2024 Apr 9:S0306-4522(24)00155.
    PubMed         Abstract available
    
    

    
    PLoS One

42. PEREIRA AAR, Pinto AM, Malerba HN, Toricelli M, et al
    Microdose lithium improves behavioral deficits and modulates molecular mechanisms of memory formation in female SAMP-8, a mouse model of accelerated aging.
    PLoS One. 2024;19:e0299534.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.